Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
From MaRDI portal
Publication:5301882
DOI10.1098/rsta.2006.1769zbMath1152.92324OpenAlexW2104800402WikidataQ51943913 ScholiaQ51943913MaRDI QIDQ5301882
Diane T. Finegood, Athanasius F. M. Marée, Richard A. Kublik, Leah Edelstein-Keshet
Publication date: 20 January 2009
Published in: Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1098/rsta.2006.1769
Related Items (7)
A mathematical model of T1D acceleration and delay by viral infection ⋮ The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance ⋮ Mathematical model for BCG-based treatment of type 1 diabetes ⋮ Modeling immune complex-mediated autoimmune inflammation ⋮ The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation ⋮ Continuum model of T-cell avidity: understanding autoreactive and regulatory T-cell responses in type 1 diabetes ⋮ Fractional Model for Type 1 Diabetes
This page was built for publication: Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
